Opioid Use Disorder (OUD) Treatment and Harm Reduction Training Using Augmented Reality (AR) Technology

使用增强现实 (AR) 技术进行阿片类药物使用障碍 (OUD) 治疗和减害培训

• 批准号: 9906749
• 负责人: DOUGLAS NELSON
• 金额: $ 22.11万
• 依托单位: LUMIS CORP.
• 依托单位国家: 美国
• 财政年份: 2019
• 资助国家: 美国
• 起止时间: 2019-09-15 至 2020-06-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/9906749
• 关键词: Accident and Emergency department; Administrator; Attitude; Augmented Reality; Basic Life Support; Cardiopulmonary Resuscitation; Caregivers; Cellular Phone; Cessation of life; Clinic; Clinical; Complex; Computer software; Credentialing; Depressed Level of Consciousness; Deterioration; Devices; Diagnosis; Disease; Drug usage; Drug user; Education; Educational Curriculum; Educational Materials; Educational Models; Effectiveness; Emergency Medical Technicians; Engineering; Epidemic; Equipment; Evaluation; Family Caregiver; Family member; Feedback; Focus Groups; Goals; Harm Reduction; Health Personnel; Health Professional; Healthcare; Hospitals; Individual; Injections; Institution; Institutional Review Boards; Interview; Knowledge; Learning; Legal patent; Logistics; Manikins; Medicine; Mission; Modality; Naloxone; National Institute of Drug Abuse; Nursing Schools; Opioid; Outcome; Overdose; Paramedical Personnel; Patients; Peripheral; Pharmaceutical Preparations; Pharmacology; Phase; Physiological; Pre-Post Tests; Process; Professional Organizations; Provider; Recommendation; Reporting; Research Methodology; Resources; School Nursing; Series; Site; Small Business Innovation Research Grant; Specialist; Standardization; Structure; Substance Use Disorder; System; Tablets; Technology; Test Result; Testing; Time; Titrations; Training; Training Programs; Training Support; Treatment outcome; United States; Universities; base; commercialization; cost; design; experience; first responder; improved; improved outcome; insight; iterative design; knowledge base; off-patent; operation; opioid mortality; opioid overdose; opioid use disorder; overdose death; peer; prescription opioid; programs; prototype; research and development; response; simulation; skills; software development; synthetic opioid; treatment services; usability

Over the last decade, death from drug overdose has created an epidemic across the United States. In 2017, there were 70,237 deaths from drug overdose, including 47,600 deaths involving opioids—a 12% increase from previous opioid overdose deaths [1]. While overdoses related to prescription opioids have decreased, synthetic opioids made up over half of all opioid-related overdose deaths and increased over 40% from the prior year [1]. The goal in this proposal is closely aligned with the mission of the National Institute of Drug Abuse (NIDA) to educate clinical providers and lay people towards improving treatment and outcomes for those suffering from substance use disorders (SUDs), specifically in response to a drug overdose. Many barriers have been identified for training providers on SUDs [2, 3]. Simulation-based training has shown promise for training providers about responding to drug overdose during Basic Life Support (BLS) training [4]. However, simulation-based training is resource intensive and can be difficult to implement as current simulator technologies require facilities, staff, and technology support. Overdose education and naloxone distribution (OEND) is associated with improved outcomes for people experiencing opioid overdose as well as decreased drug use by people who participated in OEND programs [5-11]. Increasing access to OEND could expand these positive results. The goal of this Phase I SBIR is to develop and integrate a curriculum for OEND using Lumis’s existing augmented reality (AR) healthcare simulator, the InSight Platform. The InSight Platform incorporates knowledge-based and hands-on training, requires less resources than traditional simulation, and supports broad deployment. The proposed curriculum will include a series of opioid overdose scenarios demonstrating patients in various stages of depressed level of consciousness and physiologic deterioration. These scenarios will allow clinical providers and lay people to train for evaluation, diagnosis, and treatment of an opioid overdose with naloxone. Integrating the proposed curriculum for knowledge-based and hands-on training into the InSight Platform has the potential to rapidly and broadly disseminate standardized OEND curriculum. Mixed methods research will: (1) develop and refine a curriculum for providers and patients through structured interviews with subject matter experts (SMEs), (2) integrate curriculum into Lumis’ software with iterative feedback from SMEs throughout the process, and (3) evaluate feasibility, usability, and initial learning efficacy through focus groups and training sessions with facility administrators, clinical providers, and lay people.

在过去的十年中，药物过量的死亡在美国造成了一种流行病。 2017年， 药物过量死亡70,237例，其中47,600例涉及阿片类药物的死亡，增加了12％ 从以前的阿片类药物过量死亡[1]。虽然与处方阿片类药物有关的过量药物有所改善，但 合成阿片类药物构成了所有与阿片类药物相关的过量死亡的一半以上，并从40％以上增加了 上一年[1]。该提案的目标与国家毒品研究所的使命密切相符 虐待（NIDA）教育临床提供者，并让人们改善治疗和结果 那些患有药物使用障碍（SUD）的人，特别是对药物过量的响应。 已经确定了许多有关SUD的培训提供者的障碍[2，3]。基于模拟的培训已显示 在基本生命支持（BLS）培训期间对培训提供者的承诺[4]。 但是，基于模拟的培训是资源大量的，很难作为当前模拟器实施 技术需要设施，员工和技术支持。 过量的教育和纳洛酮分布（OEND）与人们的结果改善有关 参加OEND计划的人会体验阿片类药物过量以及减少药物使用 [5-11]。增加对OEND的访问可以扩大这些积极的结果。 I阶段I SBIR的目的是使用Lumis的现有 Insight平台增强现实（AR）Healthcare Simulator。 Insight平台合并 基于知识和动手培训，比传统模拟需要的资源少，并且支持 广泛部署。拟议的课程将包括一系列阿片类药物过量场景，以证明 意识水平和生理定义的各个阶段的患者。这些场景 将允许临床提供者和外行人训练阿片类药物的评估，诊断和治疗 用纳洛酮过量服用。将拟议的课程集成为基于知识和动手培训的课程 Insight平台有可能快速和广泛地传播标准化的OEND课程。 混合方法研究将：（1）通过结构化为提供者和患者开发和完善课程 对主题专家（SME）的访谈，（2）迭代中将课程集成到Lumis的软件中 在整个过程中来自中小企业的反馈，以及（3）评估可行性，可用性和初始学习效率 通过焦点小组和与设施管理员，临床提供者和外行人员的培训。